Position in BDTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$650,237
-$91,583 QoQ
Shares Held
305,276
0.0% QoQ
Ownership
0.533%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 91.30033150329537.ToString("F0")%
Shared 0.ToString("F0")%
None 8.699668496704621.ToString("F0")%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLOBEFLEX CAPITAL L P holds $38,255,818 across 17 Biotechnology names. BDTX ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
260,706 | $11,181,680 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
450,580 | $11,156,360 | |
| 3 | RIGL |
Rigel Pharmaceuticals Inc
|
217,839 | $5,890,366 | |
| 4 | PBYI |
Puma Biotechnology, Inc.
|
349,651 | $2,234,269 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
10,594 | $2,002,795 | |
| 6 | INCY |
Incyte Corp
|
15,643 | $1,472,319 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
214,350 | $846,682 | |
| 8 | BDTX |
Black Diamond Therapeutics, Inc.
This page
|
305,276 | $650,237 |
All Filings in BDTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $650,237 | 305,276 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $741,820 | 305,276 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,156,996 | 305,276 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||